APO-OLMESARTAN/AMLODIPINE 40/5 olmesartan medoxomil 40 mg and amlodipine (as besilate) 5 mg tablet blister pack

Pays: Australie

Langue: anglais

Source: Department of Health (Therapeutic Goods Administration)

Ingrédients actifs:

amlodipine besilate, Quantity: 6.935 mg; olmesartan medoxomil, Quantity: 40 mg

Disponible depuis:

Arrotex Pharmaceuticals Pty Ltd

DCI (Dénomination commune internationale):

amlodipine besilate,Olmesartan medoxomil

forme pharmaceutique:

Tablet

Composition:

Excipient Ingredients: magnesium stearate; iron oxide yellow; titanium dioxide; silicon dioxide; powdered cellulose; polyvinyl alcohol; microcrystalline cellulose; purified talc; croscarmellose sodium; macrogol 8000

Mode d'administration:

Oral

Unités en paquet:

30

Type d'ordonnance:

(S4) Prescription Only Medicine

indications thérapeutiques:

Olmesartan and amlodipine combination tablets are indicated for the treatment of hypertension. Treatment should not be initiated with this fixed-dose combination (see Dosage and administration).

Descriptif du produit:

Visual Identification: Cream coloured, round shaped, biconvex, film coated tablets with "APO" engraved on one side and "40 over 5" on the other side.; Container Type: Blister Pack; Container Material: Al/Al; Container Life Time: 18 Months; Container Temperature: Store below 30 degrees Celsius

Statut de autorisation:

Licence status A

Date de l'autorisation:

2016-01-12